AbCellera Biologics (ABCL) Insider Trading & Ownership $2.83 +0.04 (+1.43%) (As of 09:08 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AbCellera Biologics (NASDAQ:ABCL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.00%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$18.23 MNumber OfInsiders Selling(Last 3 Years)0 Get ABCL Insider Trade Alerts Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABCL Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin AbCellera Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/26/2023Andrew BoothCFOBuy14,500$6.85$99,325.00 5/26/2023Holdings Ltd. ThermopylaeMajor ShareholderBuy153,000$6.52$997,560.00 12/16/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy85,102$10.10$859,530.20 8/19/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy200,000$11.46$2,292,000.00 6/13/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy54,915$8.03$440,967.45 6/6/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy64,545$7.50$484,087.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/16/2022Veronique LecaultCOOBuy200,000$6.34$1,268,000.00 5/12/2022Andrew BoothCFOBuy85,000$5.79$492,150.00 5/12/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy1,408,468$6.41$9,028,279.88 3/4/2022John S MontalbanoDirectorBuy10,000$8.54$85,400.00 3/1/2022John S MontalbanoDirectorBuy20,000$9.05$181,000.00 2/28/2022Veronique LecaultCOOBuy230,789$8.66$1,998,632.74 (Data available from 1/1/2013 forward) ABCL Insider Trading Activity - Frequently Asked Questions Who is on AbCellera Biologics's Insider Roster? The list of insiders at AbCellera Biologics includes Andrew Booth, Holdings Ltd. Thermopylae, John S Montalbano, and Veronique Lecault. Learn more on insiders at ABCL. What percentage of AbCellera Biologics stock is owned by insiders? 28.00% of AbCellera Biologics stock is owned by insiders. Learn more on ABCL's insider holdings. Which AbCellera Biologics insiders have been buying company stock? The following insiders have purchased ABCL shares in the last 24 months: Andrew Booth ($99,325.00), and Holdings Ltd. Thermopylae ($997,560.00). How much insider buying is happening at AbCellera Biologics? Insiders have purchased a total of 167,500 ABCL shares in the last 24 months for a total of $1,096,885.00 bought. AbCellera Biologics Key ExecutivesDr. Carl L.G. Hansen Ph.D. (Age 49)CEO, President & Chairperson Compensation: $714.94kMr. Andrew Booth M.B.A. (Age 50)Chief Financial Officer Compensation: $674.55kDr. Veronique Lecault Ph.D. (Age 39)COO & Director Compensation: $650.59kMr. Tryn T. Stimart Esq. (Age 54)J.D., M.Sc., Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer Compensation: $667.69kMarcie Thiessen CPACGA, Senior Director of Finance & AccountingDr. Ester Falconer Ph.D. (Age 49)Chief Technology Officer Kathleen Reid B.A.Head of Corporate CommunicationsGraham Craig M.Sc.Director of Corporate DevelopmentMr. Murray McCutcheon Ph.D.Senior Vice President of PartneringMr. Neil Aubuchon B.A. (Age 54)M.B.A., Chief Commercial Officer Compensation: $684.81k More Insider Trading Tools from MarketBeat Related Companies MLTX Insider Ownership EWTX Insider Ownership JANX Insider Ownership XENE Insider Ownership FOLD Insider Ownership MRUS Insider Ownership ACAD Insider Ownership ZLAB Insider Ownership VERA Insider Ownership GMTX Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:ABCL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABCL Stock Alerts